Hot Topics in Melanoma

HUB Moderator(s)

• 

  Michael Lowe, MD, MA

  Associate Professor of Surgery, Disease Team Lead and Co-Chair Melanoma Working Group
  Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University
  Atlanta, Georgia, United States

  Disclosure information not submitted.

Acral and mucosal melanoma are rare subtypes which are refractory to standard treatment. This session will explore new target and treatment options for these rare subtypes.
The second half of the session will detail the expansion in use of Mohs surgery for the treatment of melanoma in situ and very early stage melanoma.

Presentations:

• 4:02pm – 4:12pm ET

  Acral and Mucosal Melanoma- New Targets and Opportunities
  

  HUB Presenter: John R. Hyngstrom, MD – Huntsman Cancer Institute, University of Utah Health
• 4:12pm – 4:22pm ET

  Mohs versus Wide Local Excision for Melanoma and Melanoma in Situ- Current Data and Future Directions
  

  HUB Presenter: Travis W. Blalock, MD (he/him/his) – Emory University School of Medicine

  HUB Presenter: Michael C. Lowe, MD, MA – Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University
• 4:20pm – 4:30pm ET

  Questions and Discussion